SLC5A2 and hydrops fetalis: The CVD-REAL Study was a retrospective registry study designed to evaluate the association of outcomes of hospitalization for HF and all-cause death in patients with T2D treated with SGLT-2 inhibitors vs other glucose-lowering drugs.